Filing Details

Accession Number:
0001209191-21-020475
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-03-15 16:37:52
Reporting Period:
2021-03-11
Accepted Time:
2021-03-15 16:37:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1124140 Exact Sciences Corp EXAS Services-Commercial Physical & Biological Research (8731) 204782291
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1216274 Peter Graham Lidgard C/o Exact Sciences Corp.
5505 Endeavor Lane
Madison WI 53719
Chief Science Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-03-11 34,891 $21.68 73,258 No 4 M Direct
Common Stock Acquisiton 2021-03-11 8,350 $44.37 81,608 No 4 M Direct
Common Stock Disposition 2021-03-11 43,241 $130.00 38,367 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2021-03-11 34,891 $0.00 34,891 $21.68
Common Stock Stock Option (right to buy) Disposition 2021-03-11 8,350 $0.00 8,350 $44.37
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 M Direct
4,175 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 12,846 Indirect Held in 401(k) Plan
Common Stock 4,673 Indirect Held by Lidgard Family Trust Dated Aug. 1, 2008
Footnotes
  1. Represents shares of common stock received upon exercise of a stock option award.
  2. The sales reported in this field were effected pursuant to a Rule 10b5-1 trading plan.
  3. In addition to the shares of Common Stock reported on this Form 4, which total 55,886 shares, Mr. Lidgard also holds, in the aggregate, an additional 63,752 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock.
  4. These options vested and became exercisable in four equal annual installments beginning on February 23, 2018.
  5. These options vest and become exercisable in four equal annual installments beginning on February 27, 2019.